by Chris Massot | Jun 28, 2016 | Entrepreneur, Investment, Investor, SaaS
L-SPARK is Alacrity’s sister organization based in Ottawa, Ontario. L-SPARK is the only Canadian Incubator and Accelerator that focuses exclusively on Enterprise SaaS and cloud startups. With established relationships with key venture capital firms, angel...
by Chris Massot | Jun 24, 2016 | Entrepreneur, Financing, Investment, Investor, Technology, Venture Capital
With the UK voting to leave the EU in the Brexit, there is a great deal of uncertainty as to the role of London, and the UK in a post-Brexit Europe. The sky is not falling. There will be changes, and there will be uncertainties as the exit is negotiated....
by Chris Massot | Jun 17, 2016 | Entrepreneur, Financing, Innovation, Investment, Technology
Alacrity’s Global Accelerator is proud to be recognized by GUST as one the Top 10 most active seed accelerator programs in 2015! The Victoria BC based unit of The Alacrity Foundation was the only Canadian Accelerator named to the list. Other, global accelerator...
by Chris Massot | Jun 16, 2016 | Entrepreneur, Investment, Investor
A few weeks ago, we looked at the challenge of navigating mergers as an entrepreneur. This post looks at the same story of Pretio Interactive from the perspective of an investor, Owen Matthews. — The relationship between an investor and an entrepreneur is a...
by Chris Massot | May 6, 2016 | Entrepreneur, Investment, Investor, Technology
Business Insider published an interesting article “The Steroid Era of Startups is Over” overnight, the subtext of which is what happens when the boom turns to bust? It is a worthwhile read. However, the best possible lesson learned seems to have been overlooked:...
by Chris Massot | Apr 22, 2016 | Analysis, Investment
Iran is open for business and the opportunities in the Iranian market are worth exploring. The Demographics of Iran Iran has a population of a little over 80 million, (about the size of Germany), a sizable portion of which is young and well educated. After...
Recent Comments